These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18375760)

  • 21. Engineering a soluble parathyroid hormone GPCR mimetic.
    Audu CO; Plati JJ; Pellegrini M; Mierke DF
    Proteins; 2014 Jul; 82(7):1370-5. PubMed ID: 24375686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of PTH1R signaling by an extracellular binding antibody.
    Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
    Vitam Horm; 2022; 120():109-132. PubMed ID: 35953107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical stimulus alters conformation of type 1 parathyroid hormone receptor in bone cells.
    Zhang YL; Frangos JA; Chachisvilis M
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1391-9. PubMed ID: 19369447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
    Yang Y; Wang B
    Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTH1 receptor is involved in mediating cellular response to long-chain polyunsaturated fatty acids.
    Candelario J; Tavakoli H; Chachisvilis M
    PLoS One; 2012; 7(12):e52583. PubMed ID: 23300710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
    Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
    J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors.
    Yin Y; de Waal PW; He Y; Zhao LH; Yang D; Cai X; Jiang Y; Melcher K; Wang MW; Xu HE
    J Biol Chem; 2017 Jun; 292(24):9865-9881. PubMed ID: 28356352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translating in vitro ligand bias into in vivo efficacy.
    Luttrell LM; Maudsley S; Gesty-Palmer D
    Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational changes in the parathyroid hormone receptor associated with activation by agonist.
    Thomas BE; Woznica I; Mierke DF; Wittelsberger A; Rosenblatt M
    Mol Endocrinol; 2008 May; 22(5):1154-62. PubMed ID: 18258686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered Signaling and Desensitization Responses in PTH1R Mutants Associated with Eiken Syndrome.
    Portales-Castillo I; Dean T; Cheloha RW; Creemer BA; Vilardaga JP; Savransky S; Khatri A; Jüppner H; Gardella TJ
    Commun Biol; 2023 Jun; 6(1):599. PubMed ID: 37268817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
    Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X
    Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional modulation of PTH1R activation and signaling by RAMP2.
    Nemec K; Schihada H; Kleinau G; Zabel U; Grushevskyi EO; Scheerer P; Lohse MJ; Maiellaro I
    Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2122037119. PubMed ID: 35914163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
    Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
    J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling.
    Zindel D; Engel S; Bottrill AR; Pin JP; Prézeau L; Tobin AB; Bünemann M; Krasel C; Butcher AJ
    Biochem J; 2016 Nov; 473(22):4173-4192. PubMed ID: 27623777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.
    Gensure RC; Gardella TJ; Jüppner H
    Biochem Biophys Res Commun; 2005 Mar; 328(3):666-78. PubMed ID: 15694400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A salt bridge between Arg-20 on parathyroid hormone (PTH) and Asp-137 on the PTH1 receptor is essential for full affinity.
    Weaver RE; Wigglesworth MJ; Donnelly D
    Peptides; 2014 Nov; 61():83-7. PubMed ID: 25218037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of a ligand-tethered parathyroid hormone receptor.
    Monticelli L; Mammi S; Mierke DF
    Biophys Chem; 2002 Feb; 95(2):165-72. PubMed ID: 11897155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
    Cupp ME; Nayak SK; Adem AS; Thomsen WJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
    Hoare SR; Usdin TB
    Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The IRE1α-XBP1 pathway positively regulates parathyroid hormone (PTH)/PTH-related peptide receptor expression and is involved in pth-induced osteoclastogenesis.
    Tohmonda T; Yoda M; Mizuochi H; Morioka H; Matsumoto M; Urano F; Toyama Y; Horiuchi K
    J Biol Chem; 2013 Jan; 288(3):1691-5. PubMed ID: 23235147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.